Table 2.
n | Baseline | n | 3-Month | n | 6-Month | n | 12-Month | Fixed effect of randomization LSMean ± SEa | Pa | |
---|---|---|---|---|---|---|---|---|---|---|
Total Score | ||||||||||
- Placebo | 27 | 72.4±0.8 | 26 | 72.7±1.0 | 26 | 71.2±1.2 | 26 | 71.5±1.1 | 71.6±0.4 | 0.041 |
- Vitamin D | 29 | 71.7±1.1 | 29 | 73.0±1.1 | 29 | 72.8±0.9 | 26 | 72.4±1.0 | 72.8±0.4 | |
Subscales | ||||||||||
Fine Motor Precision | ||||||||||
Line Drawing | ||||||||||
- Placebo | 27 | 0.0±0.0 | 26 | 0.0±0.0 | 26 | 0.0±0.0 | 26 | 0.0±0.0 | 0.01±0.01 | 0.106 |
- Vitamin D | 29 | 0.0±0.0 | 29 | 0.0±0.0 | 29 | 0.1±0.0 | 26 | 0.0±0.0 | 0.04±0.01 | |
Fold paper | ||||||||||
- Placebo | 27 | 11.4±0.2 | 26 | 11.3±0.4 | 26 | 11.0±0.5 | 26 | 10.2±0.6b | 10.9±0.3 | 0.353 |
- Vitamin D | 29 | 11.4±0.2 | 29 | 11.3±0.2 | 29 | 11.4±0.3 | 26 | 10.8±0.5 | 11.2±0.3 | |
Fine Motor Integration | ||||||||||
Copy Square | ||||||||||
- Placebo | 27 | 4.9±0.1 | 26 | 4.9±0.1 | 26 | 5.0±0.0 | 26 | 5.0±0.0 | 4.9±0.03 | 0.460 |
- Vitamin D | 29 | 4.9±0.1 | 29 | 5.0±0.1 | 29 | 4.9±0.1 | 26 | 4.9±0.1 | 4.9±0.03 | |
Copy Star | ||||||||||
- Placebo | 27 | 4.6±0.1 | 26 | 4.6±0.1 | 26 | 4.4±0.2 | 26 | 4.5±0.2 | 4.5±0.09 | 0.522 |
- Vitamin D | 29 | 4.7±0.2 | 29 | 4.7±0.2 | 29 | 4.3±0.3 | 26 | 4.3±0.3 | 4.5±0.09 | |
Manual Dexterity | ||||||||||
Penny Transfer | ||||||||||
- Placebo | 27 | 14.4±0.4 | 26 | 15.1±0.5 | 26 | 14.8±0.5 | 26 | 14.6±0.4 | 14.8±0.2 | 0.068 |
- Vitamin D | 29 | 14.6±0.6 | 29 | 15.3±0.6 | 29 | 15.8±0.6b | 26 | 16.0±0.5b,c | 15.4±0.2 | |
Bilateral Coordination | ||||||||||
Jump in Place | ||||||||||
- Placebo | 27 | 5.0±0.0 | 26 | 5.0±0.0 | 26 | 5.0±0.0 | 26 | 5.0±0.0 | 5.0±0.04 | 0.418 |
- Vitamin D | 29 | 4.8±0.2 | 29 | 5.0±0.0 | 29 | 4.8±0.2 | 26 | 5.0±0.0 | 5.0±0.04 | |
Tap Feet & Fingers | ||||||||||
- Placebo | 27 | 10.0±0.0 | 26 | 10.0±0.0 | 26 | 10.0±0.0 | 26 | 10.0±0.0 | 10.0±0.0 | 0.999 |
- Vitamin D | 29 | 10.0±0.0 | 29 | 10.0±0.0 | 29 | 10.0±0.0 | 26 | 10.0±0.0 | 10.0±0.0 | |
Balance | ||||||||||
Line Walk | ||||||||||
- Placebo | 27 | 5.9±0.1 | 26 | 5.9±0.1 | 26 | 6.0±0.0 | 26 | 6.0±0.0 | 6.0±0.01 | 0.176 |
- Vitamin D | 29 | 6.0±0.0 | 29 | 6.0±0.0 | 29 | 6.0±0.0 | 26 | 6.0±0.0 | 6.0±0.01 | |
One Leg Balance | ||||||||||
- Placebo | 27 | 8.4±0.5 | 26 | 9.0±0.4b | 26 | 8.3±0.5 | 26 | 8.0±0.6 | 8.1±0.2 | 0.258 |
- Vitamin D | 29 | 7.4±0.6 | 29 | 8.7±0.4b | 29 | 8.3±0.4 | 26 | 8.0±0.5 | 8.4±0.2 | |
Speed and Agility | ||||||||||
One Leg Hop | ||||||||||
- Placebo | 27 | 31.5±1.36 | 26 | 31.3±1.0 | 26 | 30.6±1.2 | 26 | 31.3±1.2 | 31.6±0.6 | 0.090 |
- Vitamin D | 29 | 32.9±0.7 | 29 | 33.5±1.3 | 29 | 33.7±0.9c | 26 | 33.8±1.0 | 33.1±0.6 | |
Upper Limb Coordination | ||||||||||
Drop Catch | ||||||||||
- Placebo | 27 | 4.9±0.1 | 26 | 5.0±0.0 | 26 | 5.0±0.0 | 26 | 5.0±0.0 | 5.0±0.02 | 0.823 |
- Vitamin D | 29 | 4.9±0.1 | 29 | 5.0±0.0 | 29 | 5.0±0.0 | 26 | 5.0±0.0 | 5.0±0.02 | |
Dribble Ball | ||||||||||
- Placebo | 27 | 9.3±0.3 | 26 | 9.2±0.4 | 26 | 9.2±0.3 | 26 | 9.3±0.3 | 9.3±0.1 | 0.137 |
- Vitamin D | 29 | 9.3±0.4 | 29 | 9.3±0.3 | 29 | 9.7±0.2 | 26 | 9.8±0.2 | 9.5±0.1 | |
Strength | ||||||||||
Pushup | ||||||||||
- Placebo | 27 | 15.5±1.6 | 26 | 15.2±1.8 | 26 | 14.3±2.0 | 26 | 14.8±2.0 | 14.1±0.6 | 0.431 |
- Vitamin D | 29 | 13.6±1.7 | 29 | 14.3±1.5 | 29 | 14.1±1.3 | 26 | 14.0±1.2 | 14.8±0.6 | |
Situp | ||||||||||
- Placebo | 27 | 18.9±1.3 | 26 | 16.8±1.7b | 26 | 16.7±1.5b | 26 | 18.7±1.5 | 16.6±0.5 | 0.088 |
- Vitamin D | 29 | 16.2±1.5 | 29 | 16.4±1.3 | 29 | 16.6±1.2 | 26 | 16.6±1.5 | 17.7±0.5 |
Results are the fixed effect of randomization group from multilevel regression models testing for persistence of response at 3-12 months based on untransformed data, also controlling for time of study visit and adjusting for baseline values; data are least-squares mean (LSMean) ± standard error (SE).
Significantly different from baseline mean within randomization group by paired t-test at P<0.05.
Significantly different from placebo mean within time of study visit by Student’s t-test at P<0.05.